Compare CET & AXGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CET | AXGN |
|---|---|---|
| Founded | 1929 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Finance/Investors Services | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.5B | 1.7B |
| IPO Year | N/A | 2013 |
| Metric | CET | AXGN |
|---|---|---|
| Price | $50.24 | $33.30 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 8 |
| Target Price | N/A | ★ $38.00 |
| AVG Volume (30 Days) | 40.4K | ★ 769.6K |
| Earning Date | 01-01-0001 | 05-07-2026 |
| Dividend Yield | ★ 5.41% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $225,208,000.00 |
| Revenue This Year | N/A | $20.31 |
| Revenue Next Year | N/A | $16.36 |
| P/E Ratio | $6.93 | ★ N/A |
| Revenue Growth | N/A | ★ 20.21 |
| 52 Week Low | $40.24 | $9.22 |
| 52 Week High | $52.95 | $36.00 |
| Indicator | CET | AXGN |
|---|---|---|
| Relative Strength Index (RSI) | 47.98 | 56.37 |
| Support Level | $49.88 | $30.34 |
| Resistance Level | $51.26 | $34.25 |
| Average True Range (ATR) | 0.99 | 1.41 |
| MACD | -0.01 | 0.22 |
| Stochastic Oscillator | 68.09 | 79.15 |
Central Securities Corp is a non-diversified closed-end management investment company. Its investment objective is long-term growth of capital. The company invests in common stocks, bonds, convertible bonds, preferred stocks, convertible preferred stocks, warrants, options real estate, or short-term obligations of governments, banks, and corporations.
Axogen Inc is engaged in the science, development, and commercialization of technologies for peripheral nerve regeneration and repair. The company provides clinically and economically effective repair solutions for surgeons and health care providers. Its products include Avance Nerve Graft, Axoguard Nerve Connector, Axoguard Nerve Protector, Axoguard Nerve Cap, and Avive Soft Tissue Membrane. It also offers an Axotouch Two-Point Discriminator used to measure the innervation density of any surface area of the skin. Its products are available in the United States, Canada, Germany, the United Kingdom, Spain, and several other countries.